{{Drugbox
| verifiedrevid = 443660388
| IUPAC_name = (''RS'')-1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol
| image = Alprenolol2.svg
<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|alprenolol}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration = Oral
<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound = 80% - 90%
| metabolism =  
| elimination_half-life = 2-3 hours → 4-OH-alprenolol
| excretion =  
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 13655-52-2
| ATC_prefix = C07
| ATC_suffix = AA01
| ATC_supplemental =  
| PubChem = 2119
| IUPHAR_ligand = 563
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00866
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 2035
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 877K5MQ27W
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07156
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 51211
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 266195
<!--Chemical data-->
| chemical_formula =
| C=15 | H=23
| N=1 | O=2
| molecular_weight = 249.34 g/mol
| smiles = O(c1ccccc1C\C=C)CC(O)CNC(C)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C15H23NO2/c1-4-7-13-8-5-6-9-15(13)18-11-14(17)10-16-12(2)3/h4-6,8-9,12,14,16-17H,1,7,10-11H2,2-3H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = PAZJSJFMUHDSTF-UHFFFAOYSA-N
}}

'''Alprenolol''', or '''alfeprol''', '''alpheprol''', and '''alprenololum''' ('''Gubernal''', '''Regletin''', '''Yobir''', '''Apllobal''', '''Aptine''', '''Aptol Duriles'''), is a non-selective [[beta blocker]] as well as a [[5-HT1A receptor|5-HT<sub>1A</sub>]] and [[5-HT1B receptor|5-HT<sub>1B</sub> receptor]] [[receptor_antagonist|antagonist]],<ref name="pmid8093601">{{cite journal | vauthors = Langlois M, Brémont B, Rousselle D, Gaudy F | title = Structural analysis by the comparative molecular field analysis method of the affinity of beta-adrenoreceptor blocking agents for 5-HT1A and 5-HT1B receptors | journal = Eur. J. Pharmacol. | volume = 244 | issue = 1 | pages = 77–87 | year = 1993 | pmid = 8093601 | doi = | url = }}</ref> used in the treatment of [[angina pectoris]].<ref name="pmid4393977">{{cite journal |author=Hickie JB |title=Alprenolol ("aptin") in angina pectoris. A double-blind multicentre trial |journal=Med. J. Aust. |volume=2 |issue=6 |pages=268–72 |date=August 1970 |pmid=4393977 |doi= |url=}}</ref> It is no longer marketed by [[AstraZeneca]], but may still be available from other [[pharmaceutical_industry|pharmaceutical companies]] or [[generic drug|generically]].

==References==
{{Reflist|2}}


{{Beta blockers}}
{{Adrenergic receptor modulators}}
{{Serotonin receptor modulators}}

[[Category:5-HT1A antagonists]]
[[Category:5-HT1B antagonists]]
[[Category:Alcohols]]
[[Category:Allyl compounds]]
[[Category:Amines]]
[[Category:Beta blockers]]
[[Category:Phenol ethers]]


{{Amine-stub}}
{{Cardiovascular-drug-stub}}